1 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow LM11A-31: new trials by email Literature Review of LM11A-31 trials Research Report on LM11A-31
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LM11A-31 Safety and Tolerability in Aging People Living With HIV and Neurocognitive Impairment LM11A-31, Placebo - HIV-ASSOCIATED NEUROCOGNITIVE DISORDER (HAND) | Phase 1 / Phase 2 | Not yet recruiting | University of North Carolina, Chapel Hill | 68 | 2026-11-01 | 2026-11-18 |
| The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31 LM11A-31, Matching Placebo - PSP - Progressive Supranuclear Palsy | Phase 2 | Enrolling by invitation | Adam Boxer | 147 | 2026-07-29 | 2026-11-05 |
| The Progressive Supranuclear Palsy Clinical Trial Platform AADvac1, LM11A-31 - Progressive Supranuclear Palsy(PSP) | Phase 2 | Recruiting | Adam Boxer | 440 | 2026-07-29 | 2026-11-18 |
Supranuclear Palsy, Progressive (2) · Acquired Immunodeficiency Syndrome (1) · Cognitive Dysfunction (1) · Frontotemporal Dementia (1) · Memory Disorders (1)
Adam Boxer (2) · University of North Carolina, Chapel Hill (1)
United States (3)
Adam Boxer, MD, PhD (2) · Anne-Marie Wills, MD (2) · Irene Litvan, MD (2) · Julio Rojas-Martinez, MD, PhD (2) · Monica Diaz, MD, MS (1) · Rick Meeker, PhD (1)
R01AG085029 (2), R01AG082540 (1)